Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN952433 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Lectin, Galactoside-Binding, Soluble, 1 (LGALS1) antibody
- Antibody type
- Polyclonal
- Description
- Protein A column, followed by peptide affinity purification
- Reactivity
- Human
- Host
- Rabbit
- Vial size
- 0.4 mL
- Storage
- Store undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer.
- Handling
- Avoid repeated freezing and thawing.
Submitted references Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study.
Suppression of renal fibrosis by galectin-1 in high glucose-treated renal epithelial cells.
Identification of Galectin-1 as a novel biomarker in nasopharyngeal carcinoma by proteomic analysis.
Bailey SD, Xie C, Do R, Montpetit A, Diaz R, Mohan V, Keavney B, Yusuf S, Gerstein HC, Engert JC, Anand S, DREAM investigators.
Diabetes care 2010 Oct;33(10):2250-3
Diabetes care 2010 Oct;33(10):2250-3
Suppression of renal fibrosis by galectin-1 in high glucose-treated renal epithelial cells.
Okano K, Tsuruta Y, Yamashita T, Takano M, Echida Y, Nitta K
Experimental cell research 2010 Nov 15;316(19):3282-91
Experimental cell research 2010 Nov 15;316(19):3282-91
Identification of Galectin-1 as a novel biomarker in nasopharyngeal carcinoma by proteomic analysis.
Tang CE, Tan T, Li C, Chen ZC, Ruan L, Wang HH, Su T, Zhang PF, Xiao ZQ
Oncology reports 2010 Aug;24(2):495-500
Oncology reports 2010 Aug;24(2):495-500
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB